We MUST bring back Augusto. He knows Medical Affairs better than none other. He can rescue Acorda and bring back the days of over $ 30 bucks a share. Why are we wasting time with Mr Blank, when we can bring back a true professional in drug development to build our pipeline?!
Too late... the old saying “ you live with what you launch.” All trajectories have been set , and the market did not like what it saw, and punished. Additionally, set an ill perception with the street of Acorda ability to effectively launch a product. Digest the failure and move on... your on nobodys radar.
No way, you will see how the Acorda Team makes Inbrija a household Brand, as well-known as Tylenol. Wait, See & Learn from the Masters. They did it once before with Ampyra. And no need to bring any of those Mexicans. All they did was speak Spanish, drink coffee and dance Salsa. We DID send them BACK!!!!!!!!!!!!!!!!!!
The talent that launched Ampyra has left the building... your now stuck with leftovers that botched this launch. And yes, you will become a household name as one of the worst performing stocks of 2019 and 2018.
We are already on the rebound !!! ACOR is going to be a gold mine, but you must be patient as the market for Inbrija will grow slow at first and then grow exponentially !! Literally explode as the international market accepts it ! We have plenty of talent left in the 'building'. We have a strong C-Suite and a hard working field team !!
Call him all the names you want... your company and stock still sucks. Your leadership misled you. Your equity you received as an employee has been stripped to nothing... essentially your leadership pulled $$ out of your pocket.... not the previous poster.
You obviously not familiar with Elliott Wave and Keynesian economic model re the inflection point and long term strategy to enrich shareholders. YES we are on cusp of some big rebounds. Target price upped to 19 !! SO be patient my friend. If you are spineless then do not invest any further, just watch from the peanut gallery. If you are of strong constitution consider some buy in !! and GO GO GO !!!!!!!
Your tried this Elliot wave BS back when you were at 7-8.... don’t be a blind fool... you sound like an ingnoramus. Even if you triple your current price you are still at a 3 year low. Hang it up... you guys sound like your in a cult. Fact is many investors lost big and lost interest in you, the only thing you will attract is an unsolicited buyout for the IP, and a real Pharma company will launch this product.
There is a course on this at Harvard Business School, so it is not BS. Maybe too statistical for the average guy.
Yes, but does not fit this poor example.Folks trying to rally a buy, when hey should be busting their ass working on the business.
Habib, Harvard also has courses on leadership and effective management. The one thing they all have in common is that none apply to ACOR.